ROYAL BANK OF CANADA - ANAPTYSBIO INC ownership

ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 116 filers reported holding ANAPTYSBIO INC in Q3 2023. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ANAPTYSBIO INC
ValueSharesWeighting
Q3 2023$48,000
+54.8%
2,643
+77.5%
0.00%
Q2 2023$31,000
+24.0%
1,489
+30.4%
0.00%
Q1 2023$25,000
-64.8%
1,142
-50.1%
0.00%
Q4 2022$71,000
+208.7%
2,290
+146.0%
0.00%
Q3 2022$23,000
+43.8%
931
+16.2%
0.00%
Q2 2022$16,000
-97.7%
801
-97.1%
0.00%
Q1 2022$689,000
-50.5%
27,855
-30.5%
0.00%
Q4 2021$1,392,000
+36.1%
40,066
+6.2%
0.00%
Q3 2021$1,023,000
+4.5%
37,724
-0.1%
0.00%
Q2 2021$979,000
+4795.0%
37,777
+3944.6%
0.00%
Q1 2021$20,000934
+31033.3%
0.00%
Q3 2020$0
-100.0%
3
-93.5%
0.00%
Q2 2020$1,000
-50.0%
46
-68.5%
0.00%
Q1 2020$2,000
-93.8%
146
-92.4%
0.00%
Q4 2019$32,000
-69.2%
1,928
-35.1%
0.00%
Q3 2019$104,000
-26.2%
2,973
+18.5%
0.00%
Q2 2019$141,000
-16.6%
2,508
+8.6%
0.00%
Q1 2019$169,000
+50.9%
2,309
+31.3%
0.00%
Q4 2018$112,000
-70.3%
1,758
-53.5%
0.00%
Q3 2018$377,000
-92.1%
3,780
-94.4%
0.00%
-100.0%
Q2 2018$4,754,000
+14.6%
66,906
+67.8%
0.00%0.0%
Q1 2018$4,150,000
+1387.5%
39,877
+1342.2%
0.00%
Q4 2017$279,000
+389.5%
2,765
+68.7%
0.00%
Q3 2017$57,000
+5600.0%
1,639
+2826.8%
0.00%
Q2 2017$1,000
-87.5%
56
-81.3%
0.00%
Q1 2017$8,0003000.00%
Other shareholders
ANAPTYSBIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,950,609$35,032,9384.94%
EcoR1 Capital, LLC 7,521,024$135,077,5914.56%
Saturn V Capital Management LP 577,101$10,364,7344.34%
GREAT POINT PARTNERS LLC 894,333$16,062,2212.93%
5AM Venture Management, LLC 357,733$6,424,8851.85%
First Light Asset Management, LLC 790,806$14,202,8761.35%
Boxer Capital, LLC 1,300,000$23,348,0001.24%
Frazier Life Sciences Management, L.P. 899,700$16,158,6121.07%
Deep Track Capital, LP 1,345,813$24,170,8010.93%
Palo Alto Investors LP 431,224$7,744,7830.73%
View complete list of ANAPTYSBIO INC shareholders